Form 13-F position report

SKYE BIOSCIENCE INC COM NEW

Reported by Versant Venture Management LLC

SKYEZZZZ CUSIP 83086J309 Manager CIK 0001560009

First reported at 250,962 shares this quarter.

New
% of reported 13F value 0.37% This manager · Q3 2026
Shares 250,962 Quarter-end amount reported
Reported value $404,049 Fair value at quarter end
Consecutive quarters held 1 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2026-09-30 404049

Quarterly position history

How this manager's reported quarter-end position changed over time.

1 quarter
Quarterly reported position history for SKYE BIOSCIENCE INC COM NEW held by Versant Venture Management LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 New 250,962 +250,962 (0.0%) 0.37% $404,049 2026-11-13

Who else reported the position

28 managers reported SKYE BIOSCIENCE INC COM NEW for Q3 2026.

Managers reporting SKYE BIOSCIENCE INC COM NEW in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
5AM Venture Management LLC New 981,269 +981,269 0.53% $1,579,843 1 qtr
Versant Venture Management LLC This report New 250,962 +250,962 0.37% $404,049 1 qtr
TANG CAPITAL MANAGEMENT LLC New 200,000 +200,000 0.01% $322,000 1 qtr
BAKER BROS ADVISORS LP New 196,905 +196,905 < 0.01% $317,017 1 qtr
CITADEL ADVISORS LLC New 114,938 +114,938 < 0.01% $185,050 1 qtr
UBS Group AG New 40,461 +40,461 < 0.01% $65,142 1 qtr
BlackRock Inc New 29,107 +29,107 < 0.01% $46,862 1 qtr
GEODE CAPITAL MANAGEMENT LLC New 27,254 +27,254 < 0.01% $43,893 1 qtr
VANGUARD CAPITAL MANAGEMENT LLC New 25,985 +25,985 < 0.01% $41,836 1 qtr
JANE STREET GROUP LLC New 18,688 +18,688 < 0.01% $30,087 1 qtr
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 13, 2026
Filing type
13F-HR
Position type
Common Stock

Voting authority reported

Sole
0
Shared
250,962
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.